Karine R Begnini[Author] - Search Results

Year	Number of Results
2012	1
2013	2
2014	5
2016	3
2017	9
2018	3
2019	2
2020	3
2021	2
2022	2
2023	1
2024	1

1

The Origins of Phenotypic Heterogeneity in Cancer.

Lenz G, Onzi GR, Lenz LS, Buss JH, Dos Santos JA, Begnini KR. Lenz G, et al. Among authors: begnini kr. Cancer Res. 2022 Jan 1;82(1):3-11. doi: 10.1158/0008-5472.CAN-21-1940. Epub 2021 Nov 16. Cancer Res. 2022. PMID: 34785576 Review.

2

Cancer Cell Fitness Is Dynamic.

Lenz LS, Faccioni JL, Bracco PA, Santos JAF, Pereira LC, Buss JH, Tamborindeguy MT, Torgo D, Monteiro T, Mantovani GB, Santo CN, Marcolin JC, Dalsin E, Vigo A, Callegari-Jacques SM, Silva AO, Onzi GR, Begnini KR, Lenz G. Lenz LS, et al. Among authors: begnini kr. Cancer Res. 2021 Feb 15;81(4):1040-1051. doi: 10.1158/0008-5472.CAN-20-2488. Epub 2020 Dec 22. Cancer Res. 2021. PMID: 33355182

3

Bioimaging approaches for quantification of individual cell behavior during cell fate decisions.

Begnini KR, Pereira LC, Faccioni JL, Lenz G, Filippi-Chiela EC. Begnini KR, et al. Biochem Soc Trans. 2022 Feb 28;50(1):513-527. doi: 10.1042/BST20210534. Biochem Soc Trans. 2022. PMID: 35166330 Review.

4

Emerging Technologies to Create Inducible and Genetically Defined Porcine Cancer Models.

Schook LB, Rund L, Begnini KR, Remião MH, Seixas FK, Collares T. Schook LB, et al. Among authors: begnini kr. Front Genet. 2016 Feb 29;7:28. doi: 10.3389/fgene.2016.00028. eCollection 2016. Front Genet. 2016. PMID: 26973698 Free PMC article. Review.

5

Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer.

Buss JH, Begnini KR, Bender CB, Pohlmann AR, Guterres SS, Collares T, Seixas FK. Buss JH, et al. Front Pharmacol. 2018 Jan 12;8:977. doi: 10.3389/fphar.2017.00977. eCollection 2017. Front Pharmacol. 2018. PMID: 29379438 Free PMC article. Review.

6

The role of mitosis in generating fitness heterogeneity.

Buss JH, Lenz LS, Pereira LC, Torgo D, Marcolin J, Begnini KR, Lenz G. Buss JH, et al. J Cell Sci. 2023 Jan 1;136(1):jcs260103. doi: 10.1242/jcs.260103. Epub 2023 Jan 3. J Cell Sci. 2023. PMID: 36594556

7

The contribution of asymmetric cell division to phenotypic heterogeneity in cancer.

Buss JH, Begnini KR, Lenz G. Buss JH, et al. J Cell Sci. 2024 Mar 1;137(5):jcs261400. doi: 10.1242/jcs.261400. Epub 2024 Feb 9. J Cell Sci. 2024. PMID: 38334041 Review.

8

Synthesis, antioxidant and antitumoral activities of 5'-arylchalcogeno-3-aminothymidine (ACAT) derivatives.

da Rosa RM, Piccoli BC, da Silva FD, Dornelles L, Rocha JBT, Sonego MS, Begnini KR, Collares T, Seixas FK, Rodrigues OED. da Rosa RM, et al. Medchemcomm. 2016 Dec 22;8(2):408-414. doi: 10.1039/c6md00640j. eCollection 2017 Feb 1. Medchemcomm. 2016. PMID: 30108758 Free PMC article.

9

Antiparasitic activity of 1,3-dioxolanes containing tellurium in Trichomonas vaginalis.

Sena-Lopes Â, das Neves RN, Bezerra FSB, de Oliveira Silva MT, Nobre PC, Perin G, Alves D, Savegnago L, Begnini KR, Seixas FK, Collares T, Borsuk S. Sena-Lopes Â, et al. Biomed Pharmacother. 2017 May;89:284-287. doi: 10.1016/j.biopha.2017.01.173. Epub 2017 Feb 24. Biomed Pharmacother. 2017. PMID: 28236702

10

Antitumor potential of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-1H-pyrazoles in human bladder cancer cells.

Tessmann JW, Buss J, Begnini KR, Berneira LM, Paula FR, de Pereira CMP, Collares T, Seixas FK. Tessmann JW, et al. Biomed Pharmacother. 2017 Oct;94:37-46. doi: 10.1016/j.biopha.2017.07.060. Epub 2017 Jul 25. Biomed Pharmacother. 2017. PMID: 28750358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

24 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year